Profit attributable to owners of the parent after deducting non-recurring items grew by 1.2% YoY to approximately RMB 932 million.Dividend payment increased by 23.1% YoY ...

The addition of USDC introduces an institutional-grade stablecoin to the Pharos ecosystem. As a transparent fully-reserved dollar-denominated stablecoin, USDC will serve as a core settlement and colla ...

Fabhalta lowered likelihood of progression to kidney failure by 43% in APPLAUSE-IgAN study140.7% of patients on Fabhalta demonstrated sustained reduction of protein in urine over two years1Fabhalta gr ...

In the Phase 2 part of the AMETHYST study, litifilimab met the primary endpoint of reduction of disease activity in people living with CLE at Week 16, with more litifilimab participants achieving clea ...

Results from the Phase 3 VELA clinical trials in adults with moderate-to-severe hidradenitis suppurativa (HS) show that clinical responses continue to improve to Week 40, with 62% of patients treated ...

Thanks to the magazine and their key partners, Harvard University students now have access to a powerful new tool to combat the stress and ...

Elektros Inc. Unveils a Transformational Breakthrough in Ultra-Fast EV Charging SUNNY ISLES BEACH, FL / ACCESS Newswire / March 28, 2026 / Elektros Inc. introduces a powerful technological advancement ...

Across North America, the United States holds a dominant position in the water pump market with 90% of total market share, supported by its extensive industrial base, strong municipal infrastructure, ...

The album features 13 tracks, including 12 newly composed songs and a bonus track, "Christmas Star," created for fans, marking his most extensive tracklist to date. Blending diverse styles such as cla ...

Results HighlightsLeveraging the dual-drive strategy of "Globalisation" and "Mid-to-High-End", TCL Electronics has achieved quality growth in global business and continuously strengthened overall ...

One-year Phase 3 data for ICOTYDE to be presented at AAD 2026 demonstrate lasting skin clearance and a favorable safety profile in a once daily pill for moderate-to-severe plaque psoriasisResults furt ...

AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session Across the COAST 1, COAST 2, and SHORE phase 3 studies, amlitelimab, dosed ...